NAD deficiency due to environmental factors or gene–environment interactions causes congenital malformations and miscarriage in mice

H Cuny, M Rapadas, J Gereis… - Proceedings of the …, 2020 - National Acad Sciences
H Cuny, M Rapadas, J Gereis, EMMA Martin, RB Kirk, H Shi, SL Dunwoodie
Proceedings of the National Academy of Sciences, 2020National Acad Sciences
Causes for miscarriages and congenital malformations can be genetic, environmental, or a
combination of both. Genetic variants, hypoxia, malnutrition, or other factors individually may
not affect embryo development, however, they may do so collectively. Biallelic loss-of-
function variants in HAAO or KYNU, two genes of the nicotinamide adenine dinucleotide
(NAD) synthesis pathway, are causative of congenital malformation and miscarriage in
humans and mice. The variants affect normal embryonic development by disrupting the …
Causes for miscarriages and congenital malformations can be genetic, environmental, or a combination of both. Genetic variants, hypoxia, malnutrition, or other factors individually may not affect embryo development, however, they may do so collectively. Biallelic loss-of-function variants in HAAO or KYNU, two genes of the nicotinamide adenine dinucleotide (NAD) synthesis pathway, are causative of congenital malformation and miscarriage in humans and mice. The variants affect normal embryonic development by disrupting the synthesis of NAD, a key factor in multiple biological processes, from its dietary precursor tryptophan, resulting in NAD deficiency. This study demonstrates that congenital malformations caused by NAD deficiency can occur independent of genetic disruption of NAD biosynthesis. C57BL/6J wild-type mice had offspring exhibiting similar malformations when their supply of the NAD precursors tryptophan and vitamin B3 in the diet was restricted during pregnancy. When the dietary undersupply was combined with a maternal heterozygous variant in Haao, which alone does not cause NAD deficiency or malformations, the incidence of embryo loss and malformations was significantly higher, suggesting a gene–environment interaction. Maternal and embryonic NAD levels were deficient. Mild hypoxia as an additional factor exacerbated the embryo outcome. Our data show that NAD deficiency as a cause of embryo loss and congenital malformation is not restricted to the rare cases of biallelic mutations in NAD synthesis pathway genes. Instead, monoallelic genetic variants and environmental factors can result in similar outcomes. The results expand our understanding of the causes of congenital malformations and the importance of sufficient NAD precursor consumption during pregnancy.
National Acad Sciences